Clear Cell Renal Cell Carcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Marietta, Georgia
  • +26 more
2022-04-07
Apr 7, 2022
N
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Anchorage, Alaska
  • +814 more
2022-04-06
Apr 6, 2022
C
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer - 2013
Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • pazopanib hydrochloride
  • +2 more
  • Duarte, California
  • +1 more
2022-04-01
Apr 1, 2022
O
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
Recruiting
  • Melanoma Stage IV
  • +4 more
  • Fecal Microbiota Transplant (FMT)
  • Oslo, Norway
    Oslo University Hospital
2022-03-31
Mar 31, 2022
A
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery - 2021
Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
2022-03-18
Mar 18, 2022
N
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study
Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +33 more
2022-03-25
Mar 25, 2022
D
ABEMA Alone or in COMBO With MK-6482
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
2022-03-21
Mar 21, 2022
B
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Nivolumab and rHuPH20
  • Nivolumab
  • Chicago, Illinois
  • +104 more
2022-03-15
Mar 15, 2022
N
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +5 more
2022-03-09
Mar 9, 2022
Q
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • No intervention was required for patients or control group in this study
  • Jinan, China
    The First Affiliated Hospital of Shandong First Medical Universi
2022-03-07
Mar 7, 2022
R
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Bevacizumab
  • +3 more
  • Westwood, Kansas
  • +4 more
2022-03-03
Mar 3, 2022
M
Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cryosurgery
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-14
Feb 14, 2022
N
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Orange, California
  • +28 more
2022-03-01
Mar 1, 2022
M
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
M
Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
A
A Study of AK104 Plus Axitinib in Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • First-line Treatment
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-02-16
Feb 16, 2022
A
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +9 more
2022-02-21
Feb 21, 2022
E
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
2022-02-18
Feb 18, 2022
M
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2022-02-16
Feb 16, 2022
C
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors - 2020
Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
2022-02-16
Feb 16, 2022
A
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
2022-02-16
Feb 16, 2022
M
Safety Study of MGD009 in B7-H3-expressing Tumors - 2019
Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
2022-02-04
Feb 4, 2022
N
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery - 2021
Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
2022-01-13
Jan 13, 2022
S
Study of SRF388 in Patients With Advanced Solid Tumors
Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
2022-01-20
Jan 20, 2022
N
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer - 2015
Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Rochester, Minnesota
  • +1 more
2022-01-12
Jan 12, 2022